Your browser doesn't support javascript.
loading
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial.
Srivastava, Alok; Rangarajan, Savita; Kavakli, Kaan; Klamroth, Robert; Kenet, Gili; Khoo, Liane; You, Chur-Woo; Xu, Weiqun; Malan, Niel; Frenzel, Laurent; Bagot, Catherine N; Stasyshyn, Oleksandra; Chang, Chia-Yau; Poloskey, Stacey; Qiu, Zhiying; Andersson, Shauna; Mei, Baisong; Pipe, Steven W.
Affiliation
  • Srivastava A; Department of Haematology, Christian Medical College, Vellore, India; Centre for Stem Cell Research, inStem, Vellore, India. Electronic address: aloks@cmcvellore.ac.in.
  • Rangarajan S; Advanced Centre for Oncology, Haematology & Rare Diseases, KJ Somaiya Super Specialty Hospital, Mumbai, India; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Kavakli K; Department of Haematology, Ege University Faculty of Medicine, Children's Hospital, Izmir, Türkiye.
  • Klamroth R; Department for Internal Medicine and Vascular Medicine, Haemophilia Treatment Centre, Vivantes Hospital im Friedrichshain, Berlin, Germany.
  • Kenet G; The National Haemophilia Centre, The Amalia Biron Thrombosis Research Institute, Sheba Medical Center at Tel HaShomer, Tel Aviv University, Tel Aviv, Israel.
  • Khoo L; Haematology Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • You CW; Department of Pediatrics, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, South Korea.
  • Xu W; Department of Hematology and Oncology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Malan N; Phoenix Pharma, Port Elizabeth, South Africa.
  • Frenzel L; Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
  • Bagot CN; Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK.
  • Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine.
  • Chang CY; Hemophilia Center, Department of Pediatric Hematology/Oncology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Poloskey S; Sanofi, Cambridge, MA, USA.
  • Qiu Z; Sanofi, Bridgewater, NJ, USA.
  • Andersson S; Sanofi, Cambridge, MA, USA.
  • Mei B; Sanofi, Cambridge, MA, USA.
  • Pipe SW; Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Lancet Haematol ; 10(5): e322-e332, 2023 May.
Article in En | MEDLINE | ID: mdl-37003278
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hemophilia B / Hemophilia A Type of study: Clinical_trials / Etiology_studies Limits: Humans / Male Language: En Journal: Lancet Haematol Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hemophilia B / Hemophilia A Type of study: Clinical_trials / Etiology_studies Limits: Humans / Male Language: En Journal: Lancet Haematol Year: 2023 Type: Article